These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1758528)

  • 1. Pharmacokinetics and dose response after intravenous and subcutaneous administration of recombinant erythropoietin in patients on regular haemodialysis treatment or continuous ambulatory peritoneal dialysis.
    Stockenhuber F; Loibl U; Gottsauner-Wolf M; Jahn C; Manker W; Meisl TF; Balcke P
    Nephron; 1991; 59(3):399-402. PubMed ID: 1758528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Macdougall IC; Roberts DE; Neubert P; Dharmasena AD; Coles GA; Williams JD
    Lancet; 1989 Feb; 1(8635):425-7. PubMed ID: 2563798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of recombinant human erythropoietin in dialysis patients after single and multiple subcutaneous administrations.
    Kampf D; Eckardt KU; Fischer HC; Schmalisch C; Ehmer B; Schostak M
    Nephron; 1992; 61(4):393-8. PubMed ID: 1501734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Boelaert JR; Schurgers ML; Matthys EG; Belpaire FM; Daneels RF; De Cre MJ; Bogaert MG
    Perit Dial Int; 1989; 9(2):95-8. PubMed ID: 2488207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of recombinant human erythropoietin in chronic haemodialysis patients.
    Nielsen OJ
    Pharmacol Toxicol; 1990 Feb; 66(2):83-6. PubMed ID: 2315268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravenous and subcutaneous erythropoietin in patients on hemodialysis and continuous ambulatory peritoneal dialysis.
    Lai PC; Wu MS; Huang JY; Huang CC; Leu ML
    Changgeng Yi Xue Za Zhi; 1994 Jun; 17(2):105-12. PubMed ID: 8069732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of recombinant human erythropoietin in children treated with continuous ambulatory peritoneal dialysis.
    Reddingius RE; Schröder CH; Koster AM; Monnens LA
    Eur J Pediatr; 1994 Nov; 153(11):850-4. PubMed ID: 7843202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous versus subcutaneous administration of recombinant human erythropoietin in patients on haemodialysis and CAPD.
    Eidemak I; Friedberg MO; Ladefoged SD; Løkkegaard H; Pedersen E; Skielboe M
    Nephrol Dial Transplant; 1992; 7(6):526-9. PubMed ID: 1320232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intravenous, intraperitoneal, and subcutaneous recombinant erythropoietin in patients on CAPD. A rationale for treatment.
    Macdougall IC; Roberts DE; Neubert P; Dharmasena AD; Coles GA; Williams JD
    Contrib Nephrol; 1989; 76():112-20; discussion 120-1. PubMed ID: 2684515
    [No Abstract]   [Full Text] [Related]  

  • 10. Response of continuous peritoneal dialysis patients to subcutaneous recombinant human erythropoietin differs from that of hemodialysis patients.
    Besarab A; Golper TA
    ASAIO Trans; 1991; 37(3):M395-6. PubMed ID: 1751205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal recombinant human erythropoietin therapy: influence of the duration of continuous ambulatory peritoneal dialysis treatment and peritonitis.
    Huang TP; Lin CY
    Am J Nephrol; 1995; 15(4):312-7. PubMed ID: 7573189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of intraperitoneal, intravenous, and subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Ateshkadi A; Johnson CA; Oxton LL; Hammond TG; Bohenek WS; Zimmerman SW
    Am J Kidney Dis; 1993 Jun; 21(6):635-42. PubMed ID: 8503418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better response to s.c. erythropoietin in CAPD than HD patients.
    Stegmayr BG
    Scand J Urol Nephrol; 1997 Apr; 31(2):183-7. PubMed ID: 9165584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis].
    Zelichowski G; Lubas A; Sienkiewicz M; Janusz E; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):312-5. PubMed ID: 18634362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of subcutaneous recombinant human erythropoietin (r-Hu EPO) in CAPD patients with renal anaemia.
    Janicka L; Ksiazek A; Baranowicz I; Mierzicki P
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():67-77. PubMed ID: 8192534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Chung WW; Leung CB; Chan K; Lai KN
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of recombinant human erythropoietin in children with chronic renal failure.
    Cakar N; Ekim M; Tümer N; Yalçinkaya F; Akar N; Onaran HO
    Int Urol Nephrol; 1997; 29(3):377-83. PubMed ID: 9285314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dosage of erythropoietin in children treated with hemodialysis and continuous ambulatory peritoneal dialysis].
    Sieniawska M; Roszkowska-Blaim M
    Pediatr Pol; 1995 Dec; 70(12):1023-8. PubMed ID: 8649941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin with oral iron in peritoneal and hemodialysis patients. A comparison in an inner city population.
    Raja R; Bloom E; Goldstein M; Johnson R
    ASAIO J; 1993; 39(3):M578-80. PubMed ID: 8268603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Maintenance therapy on the anemia in continuous ambulatory peritoneal dialysis (CAPD) patients using subcutaneous administration of recombinant human erythropoietin fortnightly--a multicenter trial].
    Kubota M; Kawaguchi Y; Nomoto Y; Tsuchida H; Nihei H; Kubo K; Omori Y; Babazono T; Ogura Y; Hara S
    Nihon Jinzo Gakkai Shi; 1993 Sep; 35(9):1081-90. PubMed ID: 8230819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.